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Abstract: The purpose of this study was to examine the effects of 5-fluorouracil (5-FU) and mytomycine-C (MMC) on the success
rate of glaucoma filtration surgery (GFS). A superior fornix-based conjunctival flap was created on the right eyes of 12 rabbits
divided randomly into three equal groups termed groups 1, 2 and 3. After a small piece of sponge soaked with balanced salt solution
(BSS) in group 1 (control), 5-FU (50 mg/ ml) in group 2 and MMC (0.02 mg/ ml) in group 3 was kept on the filtration sites for 5
minutes, the filtration fistula (sclerectomy) was performed and the flap was replaced. Postoperatively, BSS, 5-FU and MMC with
doses of 0.1 ml were injected 4 times with certain intervals into the inferior fornixes of the same groups. The presence of the corneal
edema, neovascularization and defect, appearance of the filtering bleb, states of the aqueous humor, iris, lens and changes in
intraocular pressure (IOP) were observed. In one case, severe conjunctival hyperemia associated with the corneal flush and hyphema
was determined. A mild corneal edema in half the members of group 1, and all the members of groups 2 and 3, was found. The
IOP, which reduced sharply in all cases immediately after the GFS, reached its preoperative level approximately in 14, 28 and 51
days in groups 1, 2 and 3, respectively. There was a significant difference (P<0.001) both within and between the groups regarding
the survival rate of the filtering fistula. The duration of failure of the filtration bleb was also found to be short in group 1 when
compared with group 2 and in group 2 when compared with group 3. In conclusion, the success rate of the GFS was determined
to be significantly higher (P<0.001) in MMC than 5-FU and in 5-FU than in the control. Additionally, it was observed that both MMC
and 5-FU produced no persistent adverse effects on the eye tissues.
Key Words: Antiproliferatives, Glaucoma Filtration Surgery, Rabbit.

Tavflanlarda Glakom Filtrasyon Operasyonu Üzerine 5-Fluorourasil ve Mitomycin-C’nin Etkileri
Özet: Bu çal›flmada glakom filtrasyon cerrahisi’nin (GFC) baflar›s› üzerine 5-flurourasil (5-FU) ve mytomycin-C’nin (MMC) etkilerinin
incelenmesi amaçland›. Grup 1, 2 ve 3 olarak adland›r›lan üç eflit gruba rasgele ayr›lan 12 tavflan›n sa¤ gözlerinde dorsal forniks
kaideli konjunktival flap oluflturuldu. Grup 1’de serum fizyolojik, grup 2’de 5-FU (50 mg/ ml) ve grup 3’te ise MMC (0,02 mg/ ml)
ile ›slat›lm›fl küçük bir sünger parças› filtrasyon bölgesi üzerine 5 dakikal›k bir süreyle bekletildikten sonra filtrasyon fistülü
(sklerektomy) gerçeklefltirildi ve konjunktival flap yerine dikildi. Operasyondan sonra 0,1 ml dozlar›nda serum fizyolojik, 5-FU ve
MMC ayn› gruplar›n inferior forniks’lerine bellirli aral›klarla 4 kez uyguland›lar. Kornea’da ödem, neovaskülarizasyon ve defektin
varl›¤›, filtrasyon bleb’inin görünümü, humor aköz, iris, lens’in durumlar› ve göz içi bas›nc›ndaki de¤ifliklikler incelendi. Bir olguda
fliddetli konjunktival hiperemiyle birlikte korneal k›zar›kl›k ve hyphema saptand›. Grup 1’deki olgular›n yar›s›nda ve grup 2 ve 3’teki
olgular›n tümünde hafif bir corneal ödem gözlendi. Operasyondan hemen sonra h›zl› bir düflüfl gösteren göz içi bas›nc› operasyon
öncesi de¤erine, 1. 2. ve 3. grup olgularda s›ras›yla yaklafl›k olarak 14, 28 ve 51 günlerde ulaflt›. Filtrasyon fistülünün yaflam süresi
yönünden gerek grup içinde ve gruplar aras›nda belirgin bir fark (P<0,001) mevcuttu. Filtrasyon bleb’inin baflar›s›zl›kla sonuçlanma
süresi grup 2 ile karfl›laflt›r›ld›¤›nda grup 1’de ve grup 3 ile karfl›laflt›r›ld›¤›nda ise grup 2’de daha k›sa oldu¤u gözlendi. Sonuç olarak
GFC’nin baflar› oran›n›n, 5-FU’e göre MMC’de ve kontrol grubuna göre 5-FU’de belirgin bir flekilde daha yüksek (P<0,001) oldu¤u
saptand›. Ayr›ca MMC’nin ve 5-FU’in göz dokusu üzerine herhangi bir kal›c› yan etkisinin olmad›¤› gözlendi.
Anahtar Sözcükler: Antiproliferatifler, Glakom Filtrasyon Cerrahisi, Tavflan.

Introduction
Glaucoma is potentially a blinding disease. The
primary goal of its therapy is to bring the increased
intraocular pressure back to its normal level (1). For this

purpose, many medical and operative procedures are
advocated (2, 3). However, surgical intervention usually
warrants the long-term or permanent control of
intraocular pressure (IOP) in most glaucomatous cases,
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particularly with the small animals. Glaucoma filtering
surgery (GFS) or trabeculectomy is a surgical technique
designed to lower IOP by allowing the passage of aqueous
humor from the anterior chamber to the subconjuctival
space via a filtering fistula (sclerectomy) created in the
sclera (4, 5). This fistula can be blocked by a rapidly
progressing scar soon after the GFS unless required
adjunct measures are taken into consideration (5, 6).
Thus, inhibition of the scar formation is essential to
enhance the chance of surgical success and to prolong the
survival rate of the bleb (4). The agents, capable of
delaying the scar formation, are claimed to increase the
success rate of the GFS (4). For this purpose, many drugs
including bleomycine (5), corticosteroids (7), 5fluorouracil (8, 9), mytomycine-C (10, 11), toxol,
etoposide (12), daunorubicine and enthracycline
daunomycine (13) have been tried. Among them, 5fluorouracil (5-FU), a pyrimidine analog, and
mytomycine-C (MMC), an antibiotic with alkylating
properties, are known as the drugs used commonly in
both experimental and clinical studies (8, 9, 14). It has
been noted that in case of wrong or aggressive use, these
agents may cause a variety of complications, including the
erosion and necrosis of the cornea, defect of the corneal
epithelium, neovascularization of the cornea and iris,
ulceration of the sclera and wound leakage of the
conjunctiva (5, 13, 15). To lessen these complications,
alternative doses, application routes and times related to
these drugs have been researched. However, an ideal
treatment protocol has not been found yet and the
requirement for further studies has been emphasized
(16). These drugs are administered subconjunctivally
prior to and after the GFS and topically during the
surgery. Even though these administration routes can be
tried either singularly or together during a study, most
workers appear to prefer the latter form (16, 17, 18).
The purpose of this study was to examine the effects of
5-FU and MMC on the outcome of the GFS conducted on
cases undergoing the same experimental design and
treatment protocol. During this experiment, we tried to
remain focused particularly on the influence of these
drugs on the ocular tissues, IOP and bleb survival time.

(Rompun, Bayer) and 50 mg/kg ketamine hydrochloride
(Ketanes, Alce). After the right eyes of these animals
were prepared for aseptic surgery, a lid speculum was
inserted and a superior fornix-based conjunctival flap was
created at the 12 o'clock position (Figure 1). These
animals were assigned randomly to 3 equal groups called
groups 1 (control), 2 and 3. A cellulose sponge of about
5x5x5 mm in size, soaked with balanced salt solution
(BSS) in group 1, 5-FU (50 mg/ ml) (Roche) in group 2
and MMC (0.02 mg/ ml) (Onko) in group 3, was kept
between the conjunctival flap and sclera where the
filtration fistula was conducted, for 5 minutes. The
filtration sites treated with 5-FU and MMC were irrigated
thoroughly with BSS and the filtration fistula
(sclerectomy) was performed with a 1.5 mm biopsy
punch (Figure 1). The conjunctival flap was secured in
place so as to be watertight with simple interrupted
sutures using 8-0 vicryl (Ethicon) (Figure 2). BSS, 5-FU

Figure 1.

Showing an anterior fornix-based conjunctival flap and
filtration fistula (arrow).

Figure 2.

Conjunctival flap has been secured in place with simple
interrupted sutures.

Materials and Methods
The study was performed on twelve rabbits weighing
between 1.4 and 2.4 kg. They were anesthetized with an
i.m. injection of 10 mg/kg xylazine hydrochloride
310
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and MMC with doses of 0.1 ml were injected into the
inferior fornix of the operated eyes on the postoperative
days (PODs) 2, 5, 9 and 14 under anesthesia.
Postoperatively, all cases received topically terramycine
ophthalmic ointment (Pfizer) twice a day for a week. The
presence of the corneal edema, flush, ulceration and
defect, depth of the anterior chamber, state of the
aqueous humor, appearance of the filtering blebs and
presence of other unspecified lesions were investigated
daily for the first two weeks and once a week afterwards.
During this investigation, we benefitted from a pen torch,
ophthalmoscope (SMIC, China), steromicroscope (Nixon
SMZ-‘T, Japan) and fluorescein test. IOP was measured
with the schiotz tonometry (Riester, Germany) prior to
the surgery, at PODs 2, 5, 9, 14 and then once a week
up to the end of the study. To avoid bias, IOP was noted
at each time as the mean value of three independent
measurements taken at 5 minute intervals.
Macroscopically, the bleb was evaluated as either
functional (elevated and hyperemic) or non-functional
(flat and pale). The drainage of the filtering fistula was
considered to have failed when the bleb appeared
flattened and IOP was just 2 mmHg below its value
determined prior to the GFS. The follow-up period was
around 10 weeks.
Both right and left globes of all cases, exsanguinated
under deep penthobarbital anesthesia, were removed
with the subtotal exenteration method and fixed in
buffered formalin solution. Two samples, from the bleb
sites (12 o'clock position) and from the area 180° from
the bleb sites (6 o'clock position), were obtained from
each eye. After these samples were processed using
routine histologic procedures and stained with H-E, they
were examined regarding the cellular infiltration of the
conjunctiva and sclera, patent of the filtration fistula,
lesion and thickness of the cornea and states of the iris
and ciliary epithelium. The thicknesses of both right and
left corneas were measured at 4 locations with equal
intervals between the limbus and the center. The data
obtained from the measurements of IOP and corneal
thickness were analyzed with ANOVA. Results were
considered to be significant at P<0.001.

edema (Figure 3), particularly adjacent to the filtration
sites, was observed in half the cases in group 1 and all of
the cases in groups 2 and 3. It was associated with severe
conjunctival hyperemia, corneal flush near the limbus and
hyphema in one of the cases in group 1 (Figure 4). The
results of the fluorescein test were negative in all cases
except one (Figure 5).
The IOP which reduced sharply in all groups after the
GFS, persisted on average for 9 days in group 1, 21 days
in group 2 and 42 days in group 3. Then it started to rise
and reached its preoperative level approximately in 14,
28 and 51 days respectively in groups 1, 2 and 3. The
lowest IOP measured here was 9.4 mmHg, which was
determined in four rabbits, two from each of groups 2
and 3. It remained so up to POD 9 in both cases of group
2 and until POD 14 of one and POD 21 of another case
of group 3.

Figure 3.

In this photograph, corneal edema, especially adjacent to
the operation site, is observed. The bleb elevated slightly
over the sclera, is demarcated by a hyperemic area (arrow
heads).

Figure 4.

Conjunctival hyperemia and hyphema are seen.

Results
During the follow-up period, problems like wound
dehiscence, bleb rupture and adverse systemic reactions
against the drugs were not determined. A mild corneal

311

Effects of 5-Fluorouracil and Mitomycine-C on Glaucoma Filtration Surgery in Rabbits

Figure 5.

The corneal surface is stained with fluorescein.

In a functional bleb, the conjunctiva overlaying the
filtration fistula was distorted outwardly and the lumen
of the fistula was hardly distinguished (Figures 3 and 6).
In a non-functional bleb, the lumen of the fistula was
clearly visible and the conjunctiva adhered tightly to the
episclera. (Figure 7). The bleb survival rates of all groups
are shown in the Table, which demonstrates that the
duration of the bleb resulting in failure is significantly
longer in group 3 than in group 2, which is longer than
in group 1.

Figure 6.

In this photograph, the bleb elevated over the sclera,
appears hyperemic. The filtration fistula (arrow heads) is
hardly visible due to the bleb formation.

Despite some exfoliation of the epithelial and
endothelial layers of the cornea during the histologic
processing, it appeared normal in most cases. A case in
group 1 had an edematous cornea infiltrated by
inflammatory cells and mostly empty blood vessels
(Figure 8). In all groups, the lumens of the filtration
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Figure 7.

The bleb (arrow heads) became flattened and the
conjunctival flap overlying the fistula merged fully with the
sclera.

Table.

Results of the bleb survival rate recorded in three groups
during follow-up period.

Bleb survival rate (%)
Measurement
days

Group 1
(Control)

Group 2
(5-FU)

Group 3
(MMC)

2

100

100

100

5

"

"

"

9

75

"

"

14

25

"

"

21

0

75

"

28

"

25

"

35

"

0

"

42

"

"

50

49

"

"

50

56

"

"

25

63

"

"

0

fistulas were sealed with a cicatrix tissue (Figure 9) that
contained inflammatory cells in some cases (Figure 8).
The inflammatory cells were also found in the iris and
ciliary body of one case. When the data of the corneal
thickness were evaluated, significant differences between
the cases and locations were found (Figure 10). Mean
corneal thickness was about 731 µm adjacent to the
limbus and 438 µm at the center. The right corneas were
determined to be slightly thicker than the left ones. In
this regard, differences between groups were nonsignificant (Figure 10).

S. KILIÇ, A. G‹RG‹N

Discussion

Figure 8.

In this micrograph, anterior camera (ac) and iris (I) are
visible. Epithelial and enothelial layers of the cornea (c)
have exfoliated. Descemet’s membrane appears intact. The
cornea is edamatous and contains inflammatory cells and
mostly patent vessels. H-E, X20.

Figure 9.

Longitudinally sectioned lumen of a filtration fistula is
blocked partially with a cicatrix tissue (Ct). Some
inflammatory cells are observed in and around this tissue
(arrows). H-E, X20.

A variety of antiproliferative agents have been tried to
delay the early closure of the filtration fistula (5, 7, 9, 11,
12). They are administered subconjunctivally prior to or
after the GFS, or topically to the filtration site during the
surgery. However, there are some disputes on the
benefits of these application routes. Some authors (16,
18, 19) conducted work to compare the outcomes of the
subconjunctival and topical administrations or their
combinations using MMC. They found that
subconjunctival application prior to or after the GFS did
not significantly prolong the survival rate of the filtration
fistula as compared with the control. When the
subconjunctival and topical intraoperative administrations
were combined, a dramatic increase in the bleb survival
rate was found to occur (7, 19). Despite the marked
benefit of the combined treatment, the subconjunctival
way is reported to have several limitations, i.e.
discomfort to the patients, inconvenient for the physician,
expose the eyes to septic complications, increase the rates
of corneal epithelial defects and wound leakage (5, 14,
20). During the clinical examination of this study, edema
in the corneal, particularly adjacent to the filtration sites
was found. It was associated with severe conjunctival
hyperemia and corneal flush in one of the cases in group
1. The observation of the edema in control group cases as
well, rules out the possibility of the presence of any
correlation between this and the adverse effects of the
drugs. In this study, a problem like patient discomfort
was not experienced, since the subconjunctival
administration was carried out under anesthesia. This is
believed to prevent the occurrence of any risk related to
the drug application, as it allows them to be given the
subconjunctiva comfortably.
Figure 10.

Corneal thickness (µm)

1
750
1
3
600

2

2

R
L

Regarding the corneal thickness,
there is a significant difference
between the 4 locations, but a
non-significant
difference
between the right (R) and left (L)
eyes and the three groups.

3
4

450

300
Groups

Eyes

Locations

Parameters
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The studies on topical intraoperative MMC application,
noted the bleb survival rate as 30 days in rabbits (16), 56
days in monkeys (19) and 21 days in dogs (21). These
data show that various species respond differently to the
same treatment protocol. This situation is thought to be
due to differences in healing speeds between species. In
the current study, the bleb survival rate in MMC treated
cases is about 51 days, which is far greater than the value
recorded by the previous study (16). This variation is
believed to result from the treatment protocols of these
two studies.
In this study, a sharp reduction in the IOP was
detected in all groups soon after the GFS. The reduced
IOP returned to its preoperative level in 14, 28 and 51
days respectively in groups 1, 2 and 3. It can be inferred
from these parameters that the bleb survival rate of MMC
is significantly higher than that of 5-FU, which is higher
than that of the control group. This rate can be much
higher in other species when the vigorous healing
response of the rabbit wound is also taken into account
(4, 22). There are some suggestions as to how MMC and
5-FU help to keep IOP low for a long time compared to
the control (7, 11). First, they have antiproliferative
effects on the ocular cells, which may delay the filtration
fistula from being blocked by scarring (17). This is
supported by the findings of the present study. Because,
the blebs appear to survive longer in eyes treated with
drugs compared to the control group. The second
suggestion (4, 22) is that reduced IOP may persist due to
the long-lasting toxic effects of these drugs on the cells of
the ciliary process. The short episcleral application of
MMC on the unoperated rabbit eyes was found to cause
a decrease in the production of the humor aqueous (22).
However, Jampel et al. (12) suppose that this reduction
should be very low even if it is present. The absence of
marked histological changes in the ciliary processes of the
eyes treated with MMC and 5-FU in the present study
supports the claims of the former authors (12).
Additionally, the ocular signs seen in the eyes treated with
them were transient, which indicates that MMC and 5-FU
may not have serious toxic effects on the ocular tissue if
they are used properly. Gressel et al. (23) in an
experimental study on monkeys, reported that IOP
declined in non-drug-treated control eyes after the GFS.
An inhibition of the cellular secretion of the ciliary
processes by subclinical postoperative inflammation is
believed to cause this reduction. In this study,

314

postoperative inflammation was determined in some
rabbit eyes, but no difference between the IOP values of
the cases with and without ocular signs was found.
It has been reported that 5-FU enables the delaying of
the conjunctival and scleral fibroblast outgrowths for one
week more than the control. After the fibroblast
outgrowths recovered, an abnormal growth rate and
appearance were not observed (24). These findings are
compatible with those of the current study, since no
abnormal development in the scleratomized sites during
the histologic examination was determined. In contrast, it
has been reported that the cell outgrowths in the tissues
treated with MMC were significantly slower than those
treated with distilled water in specimens taken 30 days
after the surgery. Tissue culture experiments showed
that the effects of 5-FU and MMC were largely correlated
with their concentrations in, and exposure times to, the
tissues (11). Some authors (25) found that the cellular
proliferation of the rabbit ocular tissues stopped between
14 and 38 days depending on the types of, and their
exposure times to, antiproliferatives. Khaw et al. (11)
reported that 5-FU had short, but MMC had long-lasting
effects on the ocular tissues. These findings conform with
those of the current study, as the bleb survival rates of
MMC and 5-FU were found to be respectively 28 and 51
days.
Regarding the data of the corneal thickness, there
was a statistically significant difference between cases,
but a non-significant difference between the groups. The
cause of individual variations in the corneal thickness was
reported to be due to factors like the age, sex and weight
of the cases (26). The results of this study demonstrate
that the cornea becomes thinner toward its center.
Although the right and left corneas were found to differ
in thickness, it was statistically non-significant. When the
results of the control group were compared with those of
the experimental groups, no difference was found
between them. These findings also indicate that the drugs
used here do not impose any marked side effect on the
cornea.
The success rate of the GFS in MMC treated eyes was
determined to be significantly higher than that for 5-FU.
Therefore, the present authors agree with the suggestion
of Khaw et al. (11) that 5-FU can be appropriate for
cases requiring just temporary cessation of the healing
processes of the ocular tissues while MMC can be
appropriate for those which need either a temporary or

S. KILIÇ, A. G‹RG‹N

prolonged delay of the ocular healing processes.
Additionally, these drugs appear to achieve these
functions by producing no persistent adverse effects on
the eye tissues. It was concluded that MMC and 5-FU
could be considered as alternative drugs for the
treatment of glaucoma in clinical cases.
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